Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages
RBC Capital has initiated coverage on AbbVie Inc. (ABBV) with an Outperform rating and a $260 price target, asserting that the company’s growth story is still in its early stages. Despite rising awareness of Skyrizi and Rinvoq sales, RBC Capital believes investors are underestimating AbbVie’s long-term growth potential and its ability to outperform expectations. The firm also highlights AbbVie’s attractive valuation and strong earnings-per-share growth compared to competitors.